Weekly Recap | Abbvie -0.58%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 08:26 AMABBV+1.75%
Weekly Recap | Gilead Sciences -4.1%, sliding toward range lowsWeekly Review·Oct 3, 2026 at 06:52 AMGILD+1.82%
Weekly Recap | Eli Lilly -3.43%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:08 AMLLY+2.70%LLYX+5.33%
Weekly Recap | AMGN.US -2.79%, consensus target above spotWeekly Review·Oct 3, 2026 at 06:18 AMAMGN+2.60%
Weekly Recap | Johnson & Johnson -5.6%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:01 AMJNJ+1.44%
